WHEN Emma Byron was told she had only a few months to live, she went into shock. The 45-year-old had tried and failed to get ...

Aim Oral lichen planus (OLP) is a relatively common chronic inflammatory mucocutaneous disease in middle-aged individuals that often affects the oral cavity, and its prevalence has increased in recent ...

Score for each patient was calculated by recording a score for each lesion in the oral cavity separately, then calculating the average of these scores.

Presentation Details Title: Liposomal Tacrolimus (LP-310) Oral Rinse for the Treatment of Oral Lichen Planus: Topline Analysis of a Phase 2a Multicenter Dose-Ranging Trial Presenter: Dr. Alessandro ...

About the Study The Phase 2a trial is a multicenter, dose-ranging study evaluating the safety, tolerability, and efficacy of LP-310 in adults (18 years and older) with symptomatic Oral Lichen Planus.

“These findings support LP-310’s potential as a localized, non-steroidal treatment for Oral Lichen Planus. We look forward to sharing final topline data from the fully enrolled trial in the ...

The Oral Lichen Planus Phase 2a trial is a multicenter, dose-ranging study evaluating the safety, tolerability, and efficacy of LP-10 oral rinse in adults (18 years and older) with symptomatic OLP.

LP-310 shows significant improvements in pain and inflammation for oral lichen planus, with favorable safety results in Phase 2a trial. Lipella Pharmaceuticals has announced promising results from ...

Lipella Pharmaceuticals receives FDA approval for an Expanded Access Program for LP-310, targeting oral lichen planus treatment.

Frontiers Events is a rapidly growing calendar management system dedicated to the scheduling of academic events. This includes announcements and invitations, participant listings and search ...

Oral Lichen Planus (OLP) is a chronic inflammatory condition that affects the mucous membranes inside the mouth, which can cause pain and make eating, drinking and even speaking uncomfortable.

Titled "Rationale for the Use of Topical Calcineurin Inhibitors in the Management of Oral Lichen Planus and Mucosal Inflammatory Diseases,” the paper focuses on non-steroid treatments for oral lichen ...